Clinical trials of Russian cancer vaccine set for date

Last February, Russian President Vladimir Putin revealed at the Future Technologies forum in Moscow that the country was “on the verge of creating cancer vaccines.”

Health.– Clinical trials of the Russian cancer vaccine will begin in mid-2025, said Alexander Gintsburg, director of the Gamaleya National Research Center of Epidemiology and Microbiology in Moscow. These tests will involve “participation of patients with cancer”while the vaccine is currently being tested on mice, within a preclinical research.

According to Guintsburg, the technology is being developed not to simply prolong life by two or three times, but to create drugs capable of eliminating tumors. When the tests are successfully completed, The vaccine will help those suffering from lung cancers, with the exception of small cell carcinoma, pancreatic cancers, certain varieties of kidney cancer and melanomas, he specified..

The same scientist explained at the beginning of this June that it is a therapeutic and not a preventive vaccine, based on messenger RNA technology (mRNA), the same as the companies Pfizer and Moderna used in their fight once morest the coronavirus pandemic. By then, the first tests on mice of the Russian cancer vaccine had already yielded good results.

Last February, Russian President Vladimir Putin revealed at the Future Technologies forum in Moscow that the country was “on the verge of creating cancer vaccines” and suggested that discoveries of this kind in medicine “should be made available to people and widely used at the primary level of health care.”